Scilex Holding Company (NasdaqCM: SCLX)
Health Care · Pharmaceuticals · US
$2.86
-2.23% today · -80.2% 1Y
Scilex Holding Company (NasdaqCM: SCLX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $20.54M and employs 34 people.
Over the last twelve months the share price has lost 80.2%, trading between 2.86 and 27.00.
Tweenvest scores Scilex Holding Company across four factors: quality 27/100, value 57/100, growth 90/100. Its strongest factor is growth.
SCLX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $20.54M
- Revenue (TTM)
- $31.61M
- P/E
- —
- EPS
- -51.60
- Dividend yield
- —
- Beta (5Y)
- 1.79
- 52-week high
- $27.00
- 52-week low
- $2.86
- Avg volume (3M)
- —
- Shares outstanding
- 7.03M
- Employees
- 34
- Next earnings
- —
About Scilex Holding Company
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
- ISIN
- US80880W2052
- Listed since
- Mar 5, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Universe Pharmaceuticals INCNasdaqCM: UPC | $20.85M | $4.13 | -0.48% |
| Syschem (India) LimitedBSE: 531173 | $20.83M | Rs37.60 | +8.05% |
| Voyageur Pharmaceuticals Ltd.TSXV: VM | $20.62M | CA$0.13 | -7.14% |
| Cocrystal Pharma, Inc.NasdaqCM: COCP | $20.61M | $1.06 | -0.93% |
| Biofrontera AGXTRA: B8FK | $20.34M | €2.99 | -18.75% |
| Nectar Lifesciences LimitedNSEI: NECLIFE | $20.33M | Rs10.13 | -0.98% |
| Bio Medica Laboratories LimitedNSEI: BMLL | $19.88M | Rs153.00 | -4.08% |
| SynCore Biotechnology Co.,LtdTPEX: 4192 | $19.80M | NT$18.00 | -3.49% |
Figures last refreshed Oct 11, 2026.